- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus received Health Canada approval for Mesalamine suppositories 1000 mg, for ulcerative proctitis. This generic product, manufactured in India, targets a Canadian market with annual sales of 4.86 mn CAD.